BI 474121

DRUG4 trials

Sponsors

Boehringer Ingelheim

Conditions

Healthy

Phase 1

A Study in Healthy Men and Women Who Are Either Between 18 - 45 Years or Between 65 - 80 Years to Test How Different Doses of BI 474121 Are Tolerated

CompletedNCT04537897

Boehringer IngelheimHealthy

Start: 2020-10-06End: 2021-10-07Updated: 2024-03-08

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 474121 in the Blood

CompletedNCT04716894

Boehringer IngelheimHealthy

Start: 2021-02-01End: 2021-04-01Updated: 2024-03-08

A Study in Healthy Men to Test How BI 474121 is Tolerated

CompletedNCT04964453

Boehringer IngelheimHealthy

Start: 2021-07-21End: 2021-11-16Updated: 2024-03-07

A Study in Healthy Men to Test Whether BI 474121 Can Reverse the Memory Problems Caused by Ketamine

WithdrawnNCT05451095

Boehringer IngelheimHealthy

Start: 2022-11-07End: 2023-06-20Updated: 2022-08-01